Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

about

Pharmacological management of undifferentiated spondyloarthropathies.Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty.Zoledronic acid and alendronate sodium and the implications in orthodontic movement.

P2860

Q36349645-35181347-4364-4C90-AB6F-947DDCFC1A02 Q37230596-77A2D70C-13C9-47E4-9FF6-1AA91F84CC94 Q40481601-BB6B2D20-64F0-425F-956A-52C57E4DA635

P2860

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

Item

http://www.wikidata.org/entity/Q36040667

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@ast

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@en

type

Item

label

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@ast

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@en

prefLabel

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@ast

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@en

P1476

Bisphosphonates as anti-inflam ...... itis and spondylarthropathies.

@en

P2093

Eric Toussirot

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Late stent thrombosis after implantation of a sirolimus-eluting stent

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting

P304

35-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.6.1.35

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Wendling

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15709881

http://www.w3.org/2001/XMLSchema#string

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

about

P2860

P2860

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698